Uliledlimab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Uliledlimab, covering 2026-01-30 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer [Phase 2]